En esta página
01CLOV precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
CLOV Clase A Clover Health Investments, Corp. - Class A Common stock
NASDAQ · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 7, 2026
$4,38
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,58mínimo 52 semanas
$5,59máximo 52 semanas
P/E
-5.1
BPA
$-0.44
Ingresos
$1.92B
tus insignias
Rango 52S
$2–$6
Calificación del Analista
BUY
Precio Objetivo
$5
P/E
-5.1
ROE
-26.2%
Margen de Beneficio Neto
-0.74%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
CLOV Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.38
P/E
-5.1
BPA
$-0.44
Ingresos
$1.92B
ROE
-26.2%
Rango 52S
$2–$6
CLOV Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$1.92B2022-12-31 → 2025-12-31
BPA$-0.442022-12-31 → 2023-12-31
Flujo de caja libre$-69M2022-12-31 → 2025-12-31
Margen neto-0.74%2022-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | CLOV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -5.1promedio 5A ≈-4.7 | ≈-4.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | CLOV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -0.74%promedio 5A ≈-6.0% | ≈-6.0% | 3.5% | En línea | |
| Margen EBITDA (TTM) | -0.81%promedio 5A ≈-6.2% | ≈-6.2% | 3.7% | En línea | |
| Pretax Margin (Margen antes de impuestos) | -4.5% | · | 2.8% | Débil | |
| Margen de Beneficio Neto (TTM) | -0.74%promedio 5A ≈-6.0% | ≈-6.0% | 2.9% | De primer nivel | |
| ROA | -15.2%promedio 5A ≈-18.9% | ≈-18.9% | 3.0% | Débil | |
| ROE | -26.2%promedio 5A ≈-36.3% | ≈-36.3% | 10.1% | Débil | |
| ROIC | -27.7% | · | 8.0% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | CLOV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.5promedio 5A ≈1.6 | ≈1.6 | 1.7 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 0.4promedio 5A ≈0.6 | ≈0.6 | 1.3 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | CLOV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 40.3%promedio 5A ≈21.4% | ≈21.4% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 20.6%promedio 5A ≈13.8% | ≈13.8% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 23.4% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | CLOV | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 3.4promedio 5A ≈3.0 | ≈3.0 | 2.4 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$2.7M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
41.1%
Próximo informe
Nov 02, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 3, 2026 | $0.05 | $0.03 | 47.1% |
| 31 de marzo de 2026 | $0.07 | $0.03 | 128.8% | |
| 31 de diciembre de 2025 | $-0.10 | $-0.11 | 5.1% | |
| 30 de septiembre de 2025 | $-0.05 | $-0.03 | -63.4% | |
| 30 de junio de 2025 | $-0.02 | $-0.03 | 28.8% | |
| 31 de marzo de 2025 | $0.00 | $-0.06 | 100.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | $462M | |
| Gross Profit | · | · | $257M | $70M | $-79M | · | · | |
| SG&A Expense | $214M | $176M | $183M | $204M | $185M | $121M | $96M | |
| Operating Expenses | $2.01B | $1.42B | $1.47B | $1.38B | $2.11B | $766M | $645M | |
| Operating Income | $-86M | $-46M | $-205M | $-287M | $-637M | $-93M | $-183M | |
| Interest Expense | · | · | $7.0K | $1M | $3M | $36M | $23M | |
| Interest Income | · | · | · | · | · | $117.3K | · | |
| Pretax Income | $-86M | $-43M | $-213M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | $-364M | |
| EPS (Basic) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| EPS (Diluted) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| Shares (Basic) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| Shares (Diluted) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| EBITDA | $-87M | $-48M | $-213M | $-372M | $-637M | $-7M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $195M | $123M | $104M | $300M | $92M | $68M | |
| Short-term Investments | · | · | · | · | · | $0 | · | |
| Prepaid Expense | $18M | $13M | $14M | $18M | $15M | $8M | $0 | |
| Other Current Assets | $11M | $16M | $19M | $4M | $3M | $299.0K | · | |
| Current Assets | $308M | $343M | $428M | $625M | $753M | $190M | $0 | |
| PP&E (Net) | $6M | $5M | $5M | $6M | $2M | $2M | · | |
| PP&E (Gross) | $14M | $11M | $10M | $8M | $5M | $4M | · | |
| Accum. Depreciation | $8M | $6M | $5M | $2M | $2M | $2M | · | |
| Goodwill | · | · | $0 | $12M | $1M | $1M | · | |
| Other Non-current Assets | $24M | $13M | $14M | $16M | $10M | $9M | · | |
| Total Assets | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Accounts Payable | $36M | $35M | $37M | $32M | $28M | $31M | · | |
| Accrued Liabilities | · | · | · | · | · | $5M | $0 | |
| Current Liabilities | $209M | $214M | $261M | $432M | $372M | $164M | $118.0K | |
| Capital Leases | · | · | $3M | $4M | $5M | $6M | · | |
| Other Non-current Liabilities | $23M | $26M | $23M | $16M | $14M | $13M | · | |
| Total Liabilities | $232M | $240M | $284M | $452M | $411M | $433M | $118.0K | |
| Long-term Debt | · | · | · | · | $20M | $127M | · | |
| Total Debt | · | · | · | $0 | $20M | · | · | |
| Paid-in Capital | $2.68B | $2.58B | $2.46B | $2.32B | $2.15B | $412M | $0 | |
| Retained Earnings | $-2.29B | $-2.20B | $-2.16B | $-1.95B | $-1.62B | $-1.03B | $-17.6K | |
| Treasury Stock | $86M | $31M | $13M | $7M | $147.0K | $0 | · | |
| AOCI | $528.0K | $-2M | $-2M | $-9M | $-2M | $10.0K | · | |
| Stockholders' Equity | $309M | $341M | $286M | $357M | $540M | $-613M | $-17.6K | |
| Liabilities + Equity | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Shares Outstanding | · | · | · | · | 470,852,394 | 89,206,266 | · |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $-2M | $-3M | $-4M | $-2M | $200.0K | $-195.0K | $-3M | |
| Stock-based Comp | $104M | $114M | $141M | $164M | $164M | $7M | $3M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $2.0K | $2.0K | |
| Amort. of Intangibles | · | · | · | $100.0K | $700.0K | · | · | |
| Restructuring | · | $288.0K | $10M | $0 | · | · | · | |
| Other Non-cash | $-83M | $-34M | $-39M | $-28M | $142M | · | · | |
| Operating Cash Flow | $-67M | $35M | $-145M | $-204M | $-282M | $-118M | $-160M | |
| CapEx | $2M | $2M | $584.0K | $4M | $723.0K | $693.0K | $23.0K | |
| Investing Cash Flow | $4M | $565.0K | $140M | $95M | $-435M | $137M | $-182M | |
| Stock Issued | $1M | $193.0K | $1M | $0 | $284M | $0 | $0 | |
| Stock Repurchased | $18M | $2M | $0 | $0 | $147.0K | $0 | $0 | |
| Net Stock Activity | $-17M | $-2M | $-6M | $-6M | $284M | $25.0K | · | |
| Financing Cash Flow | $-53M | $-17M | $-5M | $-5M | $925M | $6M | $334M | |
| Net Change in Cash | $-116M | $18M | $-10M | $-114M | $208M | $25M | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-69M | $33M | $-116M | $-208M | $-283M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 12.7% | 0.65% | -5.4% | · | · | |
| Operating Margin | -4.4% | -3.3% | -10.2% | -10.7% | -43.3% | · | · | |
| Net Margin | -4.5% | -3.1% | -10.5% | -9.8% | -39.9% | · | · | |
| Pretax Margin | -4.5% | · | · | · | · | · | · | |
| EBITDA Margin | -4.5% | -3.5% | -10.4% | -10.7% | -43.3% | · | · | |
| ROA | -15.2% | -7.5% | -34.0% | -28.6% | -61.8% | -1.6% | · | |
| ROE | -26.2% | -12.6% | -70.2% | -91.6% | 1511.3% | -134.9% | · | |
| ROIC | -27.7% | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.6 | 1.6 | 1.4 | 2.0 | 0.8 | · | |
| Quick Ratio | 0.4 | 0.9 | 0.5 | 0.2 | 0.8 | 0.8 | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | -29791.7 | -278.3 | -197.3 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 3.4 | 2.4 | 3.2 | 2.9 | 1.5 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.76 | $2.80 | $4.22 | $7.30 | $3.56 | · | · | |
| Cash Flow / Share | $-0.13 | $0.07 | $-0.24 | $-0.43 | $-0.68 | · | · | |
| EPS (TTM) | $-0.46 | $-0.46 | $-0.44 | $-0.71 | $-1.42 | $-1.54 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 40.3% | 8.8% | 15.0% | -25.5% | 118.8% | · | · | |
| Revenue CAGR 3Y | 20.6% | -2.3% | 23.3% | · | · | · | · | |
| Revenue CAGR 5Y | 23.4% | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | · | |
| Net Income TTM | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | · | |
| P/E | -5.1 | -6.8 | -2.2 | -1.3 | -2.6 | -10.9 | · | |
| Earnings Yield | -19.6% | -14.6% | -46.2% | -76.3% | -38.2% | -9.2% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $749M | $488M | $497M | $478M | $462M | $337M | $331M | $356M | $347M | $306M | $320M | $322M | $857M | $847M | $874M | |
| Gross Profit | · | · | · | · | · | · | · | $81M | $108M | $82M | $70M | $76M | $47M | $17M | $-12M | $13M | |
| SG&A Expense | $70M | $75M | $66M | $49M | $48M | $51M | $52M | $35M | $44M | $45M | $41M | $42M | $58M | $48M | $47M | $58M | |
| Operating Expenses | $715M | $722M | $537M | $521M | $488M | $464M | $358M | $340M | $349M | $370M | $340M | $349M | $402M | $931M | $949M | $962M | |
| Operating Income | $28M | $27M | $-49M | $-24M | $-11M | $-1M | $-21M | $-9M | $7M | $-23M | $-34M | $-29M | $-80M | $-74M | $-103M | $-87M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $0 | $7.0K | $0 | $404.0K | $390.0K | $403.0K | |
| Net Income | $28M | $27M | $-49M | $-24M | $-11M | $-1M | $-22M | $-9M | $7M | $-19M | $-41M | $-29M | $-73M | $-75M | $-104M | $-75M | |
| EPS (Basic) | $0.05 | $0.05 | · | · | $-0.02 | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | |
| EPS (Diluted) | $0.05 | $0.05 | · | · | $-0.02 | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | |
| Shares (Basic) | 524,186,885 | 522,184,385 | · | 512,743,521 | 509,043,210 | 497,056,331 | · | 490,180,103 | 487,483,087 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | |
| Shares (Diluted) | 545,447,735 | 532,501,448 | · | 512,743,521 | 509,043,210 | 497,056,331 | · | 490,180,103 | 495,179,955 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | |
| EBITDA | $28M | $27M | · | $-24M | $-11M | $-2M | · | $-9M | $7M | $-23M | $-41M | $-29M | $-74M | · | $-103M | $-87M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $78M | · | · | · | $195M | $288M | $255M | $208M | $299M | $310M | $191M | $383M | $324M | $274M | |
| Prepaid Expense | $19M | $18M | $18M | $12M | $15M | $17M | $13M | $13M | $15M | $17M | $15M | $15M | $17M | $18M | $20M | $22M | |
| Other Current Assets | $20M | $23M | $11M | $12M | $15M | $16M | $16M | $3M | $4M | $5M | $1M | $3M | $3M | $37M | $26M | $17M | |
| Current Assets | $485M | $448M | $308M | $331M | $363M | $331M | $343M | $433M | $550M | $553M | $916M | $1.13B | $1.27B | $1.46B | $1.86B | $2.49B | |
| PP&E (Net) | $7M | $7M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $3M | $2M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $8M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $25M | $25M | $24M | $27M | $16M | $14M | $13M | $11M | $10M | $10M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Total Assets | $720M | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | |
| Accounts Payable | $35M | $39M | $36M | $33M | $34M | $31M | $35M | $26M | $40M | $35M | $35M | $40M | $47M | $38M | $30M | $27M | |
| Current Liabilities | $323M | $337M | $209M | $193M | $202M | $216M | $214M | $280M | $325M | $356M | $719M | $908M | $1.11B | $1.13B | $1.60B | $2.15B | |
| Capital Leases | · | · | · | · | · | · | · | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $23M | $25M | $29M | $32M | $26M | $29M | $22M | $20M | $16M | $16M | $16M | $13M | $13M | $13M | |
| Total Liabilities | $344M | $358M | $232M | $219M | $231M | $248M | $240M | $311M | $349M | $379M | $738M | $927M | $1.13B | $1.17B | $1.64B | $2.19B | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | $20M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | |
| Paid-in Capital | $2.71B | $2.70B | $2.68B | $2.66B | $2.63B | $2.60B | $2.58B | $2.55B | $2.52B | $2.49B | $2.43B | $2.40B | $2.36B | $2.28B | $2.24B | $2.20B | |
| Retained Earnings | $-2.23B | $-2.26B | $-2.29B | $-2.24B | $-2.21B | $-2.20B | $-2.20B | $-2.18B | $-2.17B | $-2.18B | $-2.09B | $-2.05B | $-2.02B | $-1.87B | $-1.80B | $-1.69B | |
| Treasury Stock | $96M | $94M | $86M | $77M | $71M | $63M | $31M | $24M | $19M | $16M | $12M | $10M | $9M | $6M | $6M | $6M | |
| AOCI | $-2M | $-672.0K | $528.0K | $471.0K | $177.0K | $-74.0K | $-2M | $852.0K | $-2M | $-3M | $-5M | $-7M | $-7M | $-11M | $-8M | $-7M | |
| Stockholders' Equity | $376M | $339M | $309M | $341M | $344M | $336M | $341M | $342M | $325M | $292M | $322M | $331M | $323M | $392M | $427M | $490M | |
| Liabilities + Equity | $720M | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 477,403,782 | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $-428.0K | $-441.0K | $-501.0K | $-396.0K | $-509.0K | $-437.0K | $-384.0K | $-522.0K | $-947.0K | $-671.0K | $-954.0K | $-930.0K | $-3M | $-695.0K | $-18.0K | $-17.0K | |
| Stock-based Comp | $9M | $12M | $25M | $26M | $26M | $26M | $30M | $28M | $28M | $29M | $33M | $36M | $39M | $43M | $42M | $41M | |
| Restructuring | · | · | · | · | · | · | · | $-538.0K | $473.0K | $353.0K | $1M | $5M | $2M | · | · | · | |
| Other Non-cash | · | $69M | · | · | · | $-41M | · | · | · | $17M | · | · | $114M | · | · | $-22M | |
| Operating Cash Flow | $25M | $108M | $-68M | $12M | $5M | $-16M | $-86M | $50M | $45M | $26M | $-19M | $53M | $79M | $102M | $-39M | $-57M | |
| CapEx | $682.0K | $854.0K | $597.0K | $692.0K | $569.0K | $185.0K | $315.0K | $399.0K | $397.0K | $445.0K | $243.0K | $354.0K | $251.0K | $259.0K | $173.0K | $158.0K | |
| Investing Cash Flow | $-32.0K | $-5M | $-35M | $-5M | $36M | $9M | $-1M | $-12M | $5M | $9M | $-20M | $66M | $10M | $-43M | $89M | $37M | |
| Stock Issued | · | · | $541.0K | $0 | · | · | $193.0K | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $0 | $0 | $1.0K | $0 | $18M | $0 | $0 | $-2M | $0 | $-3M | $-3M | $3M | $276.0K | $105.0K | $6M | |
| Net Stock Activity | · | $0 | · | · | · | $-18M | · | · | · | $-3M | · | · | $-3M | · | · | $-6M | |
| Financing Cash Flow | $416.0K | $-8M | $-9M | $-5M | $-8M | $-32M | $-6M | $-5M | $-3M | $-3M | $-2M | $-147.0K | $-2M | $132.0K | $458.0K | $-6M | |
| Net Change in Cash | $26M | $95M | $-112M | $1M | $33M | $-39M | $-93M | $33M | $47M | $32M | $-41M | $120M | $87M | $58M | $51M | $-26M | |
| Free Cash Flow | · | $107M | · | · | · | $-16M | · | · | · | $25M | · | · | $79M | · | · | $-57M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 24.5% | 30.3% | 23.6% | 13.1% | 14.9% | 10.5% | · | -1.4% | 1.5% | |
| Operating Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.6% | 2.0% | -6.5% | -8.6% | -5.6% | -13.8% | · | -12.1% | -10.0% | |
| Net Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.8% | 2.1% | -5.5% | -8.6% | -5.6% | -13.8% | · | -12.3% | -8.6% | |
| EBITDA Margin | 3.8% | 3.6% | · | -4.9% | -2.2% | -0.37% | · | -2.6% | 2.0% | -6.7% | -8.6% | -5.6% | -13.9% | · | -12.1% | -10.0% | |
| ROA | 4.3% | 4.3% | · | -4.0% | -1.7% | -0.20% | · | -1.1% | 0.77% | -1.8% | -3.2% | -1.7% | -3.5% | · | -6.3% | -4.2% | |
| ROE | 7.8% | 8.1% | · | -7.1% | -3.2% | -0.41% | · | -2.8% | 2.3% | -6.2% | -11.6% | -7.6% | -17.9% | · | -28.2% | -14.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.3 | · | 1.7 | 1.8 | 1.5 | · | 1.5 | 1.7 | 1.6 | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.2 | |
| Quick Ratio | · | · | · | · | · | · | · | 1.0 | 0.8 | 0.6 | 0.4 | 0.3 | 0.2 | · | 0.2 | 0.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4115.3 | · | · | -262.9 | -216.6 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.2 | · | 0.8 | 0.8 | 0.7 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.3 | 0.3 | · | 0.5 | 0.5 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.89 | · | |
| Revenue / Share | $1.36 | $1.41 | · | $0.97 | $0.94 | $0.93 | · | $0.68 | $0.72 | $0.71 | $1.00 | $1.07 | $1.10 | · | $1.78 | $1.85 | |
| Cash Flow / Share | · | $0.20 | · | · | · | $-0.03 | · | · | · | $0.05 | · | · | $0.17 | · | · | $-0.12 | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.68 | · | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.97 | $-0.89 | $-1.45 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.21B | · | $1.77B | $1.61B | $1.49B | · | $1.35B | $1.32B | $1.29B | $-533M | $18M | $544M | $3.01B | $2.58B | $2.15B | |
| Net Income TTM | $-18M | $-57M | · | $-58M | $-43M | $-25M | · | $-91M | $-124M | $-160M | $-227M | $-261M | $-337M | $-443M | $-402M | $-615M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.02B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $717M | · | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | · | · | -1.8 | -2.4 | -2.4 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.4 | · | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | · | · | -57.1% | -41.6% | -40.8% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Ingresos | $1.92B | $1.37B | $1.26B | · | · |
| Margen Bruto % | · | · | 12.7% | · | · |
| Margen Operativo % | -4.4% | -3.3% | -10.2% | · | · |
| Beneficio neto | $-86M | $-43M | $-213M | · | · |
| EPS Diluido | · | · | $-0.44 | · | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Ratio corriente | 1.5 | 1.6 | 1.6 | · | · |
| Ratio Rápido | 0.4 | 0.9 | 0.5 | · | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-69M | $33M | $-116M | · | · |
Propietarios institucionales (13F) 246 declarantes · $880.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
246
Valor en tenencia
$880.9M
Nuevas posiciones
43
Posiciones cerradas
25
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 43 (-6 vs trimestre anterior) | 25 (+3 vs trimestre anterior) | 84 (+28 vs trimestre anterior) | 57 (-5 vs trimestre anterior) | +24.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $183 960 495 | 35 106 965 | 20,88% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $94 517 344 | 18 037 661 | 10,73% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $56 844 123 | 10 846 066 | 6,45% | Acciones |
| VANGUARD GROUP INC | $55 191 894 | 23 485 912 | 6,27% | Acciones |
| STATE STREET CORP | $53 344 966 | 10 180 337 | 6,06% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $37 756 296 | 7 205 400 | 4,29% | Opción de compra |
| Nuveen, LLC | $32 968 503 | 6 291 699 | 3,74% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28 931 025 | 5 521 188 | 3,28% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $23 425 168 | 4 470 452 | 2,66% | Acciones |
| NORTHERN TRUST CORP | $19 768 424 | 3 772 600 | 2,24% | Acciones |
| PNC Financial Services Group, Inc. | $18 674 700 | 3 563 874 | 2,12% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $16 501 126 | 3 148 626 | 1,87% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $15 300 239 | 2 919 893 | 1,74% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $14 710 991 | 2 807 441 | 1,67% | Acciones |
| MORGAN STANLEY | $12 022 159 | 2 294 305 | 1,36% | Acciones |
| CITADEL ADVISORS LLC | $11 335 194 | 2 163 205 | 1,29% | Acciones |
| D. E. Shaw & Co., Inc. | $10 299 183 | 1 965 493 | 1,17% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9 456 104 | 1 804 600 | 1,07% | Opción de venta |
| MARSHALL WACE, LLP | $8 191 111 | 1 563 189 | 0,93% | Acciones |
| Invesco Ltd. | $7 004 779 | 1 336 790 | 0,80% | Acciones |
| GMT Capital Corp | $6 839 248 | 1 305 200 | 0,78% | Acciones |
| MACKENZIE FINANCIAL CORP | $6 798 774 | 1 297 476 | 0,77% | Acciones |
| JANE STREET GROUP, LLC | $6 767 161 | 1 291 443 | 0,77% | Acciones |
| Cerity Partners LLC | $6 460 322 | 1 232 886 | 0,73% | Acciones |
| CAXTON ASSOCIATES LLP | $6 375 146 | 1 216 631 | 0,72% | Acciones |
| Bank of New York Mellon Corp | $6 346 194 | 1 211 106 | 0,72% | Acciones |
| CITADEL ADVISORS LLC | $6 236 124 | 1 190 100 | 0,71% | Opción de venta |
| GOLDMAN SACHS GROUP INC | $6 134 688 | 1 170 742 | 0,70% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $5 809 698 | 1 108 721 | 0,66% | Acciones |
| Point72 Asset Management, L.P. | $5 604 940 | 1 069 645 | 0,64% | Acciones |
| CITADEL ADVISORS LLC | $5 373 096 | 1 025 400 | 0,61% | Opción de compra |
| JANE STREET GROUP, LLC | $4 378 020 | 835 500 | 0,50% | Opción de compra |
| Swiss National Bank | $4 315 140 | 823 500 | 0,49% | Acciones |
| GROUP ONE TRADING LLC | $3 915 532 | 747 239 | 0,44% | Acciones |
| IMC-Chicago, LLC | $3 369 477 | 643 030 | 0,38% | Acciones |
| WOLVERINE TRADING, LLC | $3 096 288 | 992 400 | 0,35% | Opción de compra |
| TUDOR INVESTMENT CORP ET AL | $2 808 116 | 535 900 | 0,32% | Opción de compra |
| RHUMBLINE ADVISERS | $2 726 870 | 520 397 | 0,31% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $2 558 074 | 488 182 | 0,29% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2 528 269 | 482 494 | 0,29% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 421 577 | 462 133 | 0,27% | Acciones |
| DEUTSCHE BANK AG\ | $2 309 776 | 440 797 | 0,26% | Acciones |
| UBS Group AG | $2 145 519 | 409 450 | 0,24% | Acciones |
| WELLS FARGO & COMPANY/MN | $2 070 099 | 395 057 | 0,23% | Acciones |
| Legal & General Group Plc | $2 032 108 | 387 807 | 0,23% | Acciones |
| ALGERT GLOBAL LLC | $1 965 419 | 375 080 | 0,22% | Acciones |
| PEAK6 LLC | $1 954 520 | 373 000 | 0,22% | Opción de compra |
| BANK OF AMERICA CORP /DE/ | $1 860 273 | 355 014 | 0,21% | Acciones |
| JPMORGAN CHASE & CO | $1 673 457 | 296 369 | 0,19% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 607 129 | 306 704 | 0,18% | Acciones |
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| ChaChaCha SPAC C LLC, Chamath Palihapitiya | 4 de octubre de 2022 | · | Presentación inicial | · | SEC |
| SCH Sponsor III LLC, ChaChaCha SPAC C LLC, Chamath Palihapitiya, Ian Osborne ×2 presentaciones | 14 de enero de 2022 | · | Presentación inicial | · | SEC |
| Vivek Garipalli | 19 de enero de 2021 | · | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 29 insiders · 15 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Andrew Toy | Chief Executive Officer | 1 de octubre de 2026 S | 9 140 510 | 0 | 4 | $-3 704 610 |
| Jamie L. Reynoso | CEO, Medicare Advantage | 17 de septiembre de 2026 S | 2 803 446 | 0 | 16 | $-456 213 |
| Conrad Wai | CEO, Counterpart Health | 15 de septiembre de 2026 S | 1 170 056 | 0 | 3 | $-2 408 584 |
| Brady Patrick Priest | CEO of Clover Care Services | 13 de mayo de 2026 S | 2 040 222 | 0 | 2 | $-724 847 |
| Aric R Sharp | CEO of Value Based Care | 9 de agosto de 2024 F | 2 100 665 | 0 | 0 | $0 |
| Joseph Clay Thornton | Interim CFO | 17 de agosto de 2026 S | 1 249 526 | 0 | 2 | $-99 654 |
| Peter J. Kuipers | Chief Financial Officer | 29 de enero de 2026 F | 5 758 353 | 0 | 0 | $0 |
| Scott J. Leffler | Chief Financial Officer | 25 de enero de 2024 F | 4 857 303 | 0 | 0 | $0 |
| Joseph F. Wagner | Chief Financial Officer | 9 de agosto de 2021 C | 25 000 | 0 | 0 | $0 |
| Joseph Frank Oldakowski | VP OF FINANCE AND CONTROLLER | 16 de septiembre de 2026 S | 275 897 | 0 | 3 | $-176 725 |
| Karen Soares | Chief Legal Officer | 15 de septiembre de 2026 S | 1 607 371 | 0 | 4 | $-336 594 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | Chief Technology Officer | 31 de octubre de 2023 A | 3 093 225 | 0 | 0 | $0 |
| Joseph Richards Martin | General Counsel | 14 de junio de 2023 F | 2 718 857 | 0 | 0 | $0 |
| Prabhdeep Singh | Chief Growth Officer | 16 de septiembre de 2022 A | 872 821 | 0 | 0 | $0 |
| Gia Lee | General Counsel & Secretary | 7 de enero de 2021 A | · | 0 | 0 | $0 |
| Brian James Miller | Consejero | 30 de septiembre de 2026 A | 12 481 | 0 | 0 | $0 |
| Robert G Torricelli | Consejero | 30 de septiembre de 2026 A | 186 897 | 0 | 0 | $0 |
| Carladenise Armbrister Edwards | Consejero | 18 de mayo de 2026 S | 285 432 | 0 | 1 | $-229 687 |
| Vivek Garipalli | Consejero | 7 de enero de 2026 M | 1 856 247 | 0 | 0 | $0 |
| Anna U Loengard | Consejero | 6 de enero de 2026 A | 527 456 | 0 | 0 | $0 |
| Demetrios L. Kouzoukas | Consejero | 6 de enero de 2026 A | 605 980 | 0 | 0 | $0 |
| William G Robinson Jr | Consejero | 6 de enero de 2026 A | 597 987 | 0 | 0 | $0 |
| Thomas L Tran | Consejero | 6 de enero de 2026 A | 180 029 | 0 | 0 | $0 |
| Chelsea Clinton | Consejero | 6 de enero de 2025 A | 602 814 | 0 | 0 | $0 |
| Lee Shapiro | Consejero | 6 de enero de 2025 A | 598 622 | 0 | 0 | $0 |
| Nathaniel S. Turner | Consejero | 7 de enero de 2021 A | · | 0 | 0 | $0 |
| Ian Osborne | Propietario del 10% | 7 de enero de 2021 M | 25 500 000 | 0 | 0 | $0 |
| James Ryans | · | 7 de enero de 2021 M | 100 000 | 0 | 0 | $0 |
| Jacqueline D Reses | · | 7 de enero de 2021 M | 300 000 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 25 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 0,72% | 609 410 SH | 1 de octubre de 2026 | Diario |
| IHF · iShares Trust | 0,28% | 778 656 SH | 11 de septiembre de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,26% | 158 213 SH | 1 de octubre de 2026 | Diario |
| IWO · iShares Trust | 0,13% | 3 960 261 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 451 034 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,10% | 649 882 SH | 1 de octubre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 2 420 762 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,07% | 10 919 497 SH | 11 de septiembre de 2026 | Diario |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 109 827 NS | 31 de julio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,06% | 201 395 NS | 31 de julio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,03% | 1 226 414 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 193 636 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 4 645 340 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,02% | 23 436 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 502 203 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 615 231 SH | 11 de septiembre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,00% | 23 911 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 109 551 SH | 11 de septiembre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 228 838 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 21 592 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 486 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 12 982 885 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 34 580 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 19 297 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 91 976 SH | 11 de septiembre de 2026 | Diario |
CLOV Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 10 analistas
COMPRA
Objetivo mediano
$5.25
+19,9%
2 20,0%
Compra fuerte
4 40,0%
Compra
4 40,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-09-30Objetivo medio $5.38 +22,7%
← Por Debajo de Todos los Objetivos
Precio Actual $4.38
Mín$5.00
Media$5.38
Máx$6.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 7, 2026